Literature DB >> 8945924

Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo.

X L Ma1, B L Lopez, T A Christopher, D S Birenbaum, J Vinten-Johansen.   

Abstract

This study tested the hypothesis that exogenous nitric oxide (NO) inhibits basal release of NO in isolated rat aortic rings and in vivo. Thoracic aortic rings were suspended in organ chambers with Krebs-Henseleit solution. In untreated rings, the NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) markedly increased basal vascular tone by 34.6 +/- 5.2% of maximal force produced by 100 nM thromboxane A2 mimetic U-46619, indicating a basal release of NO. Other rings were pretreated with the exogenous NO donor S-nitroso-N-acetylpenicillamine (SNAP) for 20 min and then washed free of drug. In these rings, L-NAME-induced vasoconstriction was significantly attenuated in a concentration-dependent manner (from 34.6 +/- 5.2 to 25.7 +/- 2.9% at SNAP = 0.5 microM, 15.2 +/- 3.1% at 1 microM, and 11.9 +/- 2.5% at 5 microM), while having no effect on NO-independent phenylephrine-induced vasoconstriction (35.4 +/- 4.7 untreated vs. 41.3 +/- 4.3% SNAP pretreated, not significant). In addition, the nonnitrosylated parent molecule of SNAP, acetylpenicillamine, had no effect on the vasoconstriction induced by L-NAME. In the in vivo studies in anesthetized rats, L-NAME caused significant hypertensive responses (34 +/- 4-mmHg increase in mean arterial blood pressure). Subvasoactive doses of SNAP attenuated these hypertensive responses in a dose-dependent manner (20 +/- 3-mmHg increase with 10 micrograms/kg SNAP pretreatment and 16 +/- 4-mmHg increase with 20 micrograms/kg SNAP pretreatment), but any dose of acetylpenicillamine studied had no effect. Coadministration of superoxide dismutase and SNAP significantly potentiated the inhibitory effect of the NO donor on vasocontraction responses to L-NAME. Furthermore, SNAP did not attenuate the hypertensive responses to phenylephrine. These results indicate that exogenous NO significantly inhibits basal NO release both in vitro and in vivo, suggesting that NO plays an important negative-feedback regulatory role under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945924     DOI: 10.1152/ajpheart.1996.271.5.H2045

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Regulation of nitric oxide consumption by hypoxic red blood cells.

Authors:  Tae H Han; Erion Qamirani; Allyson G Nelson; Daniel R Hyduke; Gautam Chaudhuri; Lih Kuo; James C Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

2.  Mechanism and kinetics of inducible nitric oxide synthase auto-S-nitrosation and inactivation.

Authors:  Brian C Smith; Nathaniel B Fernhoff; Michael A Marletta
Journal:  Biochemistry       Date:  2012-01-24       Impact factor: 3.162

3.  Nitric oxide inhibits capacitative Ca2+ entry and enhances endoplasmic reticulum Ca2+ uptake in bovine vascular endothelial cells.

Authors:  Elena N Dedkova; Lothar A Blatter
Journal:  J Physiol       Date:  2002-02-15       Impact factor: 5.182

4.  Flow dependence and time constant of the change in nitric oxide concentration measured in the vascular media.

Authors:  S Mochizuki; M Goto; Y Chiba; Y Ogasawara; F Kajiya
Journal:  Med Biol Eng Comput       Date:  1999-07       Impact factor: 2.602

5.  Inhaled nitric oxide applications in paediatric practice.

Authors:  A Bernasconi; M Beghetti
Journal:  Images Paediatr Cardiol       Date:  2002-01

Review 6.  The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?

Authors:  Frederico Vieira; Marjorie Makoni; Edgardo Szyld; Krishnamurthy Sekar
Journal:  Front Pediatr       Date:  2021-03-31       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.